Merz, M., Mai, E. K., Bertsch, U., Hose, D., Seckinger, A., Jauch, A., . . . Goldschmidt, H. (2016). Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial. Haematologica, 101(12), . https://doi.org/10.3324/haematol.2016.151266
Chicago-Zitierstil (17. Ausg.)Merz, Maximilian, et al. "Peripheral Neuropathy Associated with Subcutaneous or Intravenous Bortezomib in Patients with Newly Diagnosed Myeloma Treated Within the GMMG MM5 Phase III Trial." Haematologica 101, no. 12 (2016). https://doi.org/10.3324/haematol.2016.151266.
MLA-Zitierstil (9. Ausg.)Merz, Maximilian, et al. "Peripheral Neuropathy Associated with Subcutaneous or Intravenous Bortezomib in Patients with Newly Diagnosed Myeloma Treated Within the GMMG MM5 Phase III Trial." Haematologica, vol. 101, no. 12, 2016, https://doi.org/10.3324/haematol.2016.151266.